Grand Opening Celebration for Promega cGMP Manufacturing Facility Will Focus on Detail, Diagnostics and Discovery

MADISON, WISCONSIN — Promega will host a grand opening celebration for its new cGMP manufacturing facility, the Feynman Center, on October 11. The event, open to the public, will provide community, customers and employees an opportunity to tour the facility and to learn more about the science behind the production of molecular tools and technologies.

Grand Opening Celebration – Promega cGMP Manufacturing Facility

WHERE:

Promega Feynman Center

2780 Woods Hollow Road, Fitchburg, WI 53711

WHEN:

October 11, 2013

3:00-8:00pm

Dedication Ceremony

3:30-4:30pm

Tours, entertainment, refreshments

4:30-8:00pm

The Feynman Center bypasses the mold of a traditional manufacturing facility, assimilating detailed designs and aspects of the outside world to convey a sense of warmth, passion for discovery and a desire to combine present standards with a vision for the future. The state-of-the-art 260,000-square-foot facility is dedicated to serving customers in need of molecular biology reagents for In Vitro diagnostic (IVD) assays.

“We wanted the capabilities of the Feynman Center to not only meet today’s regulations and capacity for flexibility, but also anticipate what’s to come and continue to serve the latest applications of molecular tools,” said Bill Linton, President and CEO of Promega Corporation.

Primarily devoted to meeting Current Good Manufacturing Practice (cGMP) standards and manufacturing molecular technology tools, the Feynman Center also features a unique area – the Crossroads, for Promega guests and employees. The Crossroads incorporates spaces for training, lab demonstrations, fitness and dining. It also features “Third Spaces” for employees, to foster creative thinking and collaboration.

The Grand Opening will include tours and scientific activities for guests. The Dedication Ceremony will feature presentations from Jeanette Roberts, Dean of the Pharmacy School at UW-Madison, and a few words from the building designers and Promega leadership.

“We are excited to make a contribution in the biotechnology sector. This facility is the thoughtful work of nearly 500 architects, designers, consultants, tradesmen, and Promega employees. It’s thanks to them that we can continue to evolve and expand as a corporation and as a member of this community,” said Jen Romanin, Director of IVD Operations at Promega.

< | >